A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
C4 Therapeutics, Inc.
C4 Therapeutics, Inc.
Amgen
Imugene Limited
Amgen
Faculdade de Ciências Médicas de Minas Gerais
GlaxoSmithKline
OncoNano Medicine, Inc.
Amgen
University of Texas Southwestern Medical Center
Amgen
Amgen
Nanjing First Hospital, Nanjing Medical University
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Rabin Medical Center
University Health Network, Toronto
Istanbul Saglik Bilimleri University
Cairo University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Stingthera, Inc.
Universitätsklinikum Hamburg-Eppendorf
Beijing Chao Yang Hospital
Zonguldak Bulent Ecevit University
Mansoura University
The Catholic University of Korea
Kansas City Veteran Affairs Medical Center
Beijing Chao Yang Hospital
Cairo University
National Cancer Institute, Egypt
Mayo Clinic
Mater Misericordiae University Hospital
Rajiv Gandhi Cancer Institute & Research Center, India
Eastern Hepatobiliary Surgery Hospital
Eastern Hepatobiliary Surgery Hospital
CSA Medical, Inc.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH
Tang-Du Hospital
Karolinska Institutet
National University Hospital, Singapore